How Much Does Descovy Cost?

At the US pharmacies in our data, the lowest listed discount-card price for Descovy is around $2,261.38. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.

Canadian pharmacy listings in our data show Descovy priced from about $1.78 per tablet (converted to USD), before shipping. Pack size and pharmacy both affect the final total — see the Canada pricing table for specifics.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Descovy.

Generic and brand-name pricing for Descovy is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

No. Descovy is manufactured by Gilead Sciences, Inc., and a generic (bioequivalent) version is not currently on the market. It is only available as a brand-name medication.

Descovy is a fixed-dose combination of two antiretroviral drugs, emtricitabine and tenofovir alafenamide. It has two primary FDA-approved uses. First, it is used in combination with other antiretroviral agents to treat HIV-1 infection in adults and pediatric patients meeting specific weight criteria. Second, it is approved for HIV-1 pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents (weighing at least 77 pounds) to reduce the risk of acquiring HIV through sex, excluding those at risk from receptive vaginal sex or injection drug use. Important safety notes: Descovy is not a cure for HIV, does not prevent other sexually transmitted infections or pregnancy, and is not a complete HIV treatment regimen on its own. It carries a boxed warning regarding the potential for severe worsening of hepatitis B upon discontinuation and the requirement for confirmed HIV-negative status before and during use for PrEP. Never skip doses or stop taking Descovy without consulting your doctor, as this can lead to treatment failure and drug resistance.

Descovy is supplied as oral tablets in two strengths: 200 mg of emtricitabine combined with 25 mg of tenofovir alafenamide, and 120 mg of emtricitabine combined with 15 mg of tenofovir alafenamide. The appropriate strength is determined by a healthcare provider based on the patient's age, weight, and indication.